Session Time: 5:30pm-7:30pm
Presentation Time: 5:30pm-7:30pm
Location: Hall 4EF
BACKGROUND: A UNOS/OPTN policy approved in 2015 allowed simultaneous pancreas-kidney transplants (SPK) for type-2 diabetic patients. We examined the effect of this policy on volume of SPK as well as outcomes of type-2 diabetic patients receiving SPK at our center.
RESULTS: From Jan 2007 to Nov 2017, we did 78 SPK. Prior to Jan 2015, SPK were performed only for type-1 diabetic patients (N=42) and after 2015, SPK were done for both type-1 (N=26) and type-2 diabetic patients (N=10)-Figure-1. All type-2 diabetic patients receiving SPK had C-peptide>2, were on insulin, and had BMI≤30 pre-transplant (Tx). The characteristics of type-1 vs. type-2 diabetic patients with SPK pre- and post-Tx are shown in Table-1.
|TYPE-1 DM WITH SPK (N=68)||TYPE-2 DM WITH SPK (N=10)||P-VALUE|
|AFRICAN AMERICAN RACE (%)||26(38%)||5(50%)||NS|
Type 2 diabetic SPK patients gained more wt. post-Tx compared with type-1 patients. All type 2 diabetic SPK patients were alive and had working pancreas and kidney Tx with no insulin use till last f/u.
CONCLUSION: New pancreas Tx allocation policy has helped improve pancreas transplant volume at our center, with 28% of all SPK done in type-2 diabetic patients since Jan 2015 with excellent short-term outcomes.
CITATION INFORMATION: Singh N., Pulisetty A., Aultman D., McMillan R., Zibari G., Shokouh-Amiri H. Impact of New Pancreas Transplant Allocation Policy on Pancreas Transplant Volume and Outcomes: A Single Center Study Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Singh N, Pulisetty A, Aultman D, McMillan R, Zibari G, Shokouh-Amiri H. Impact of New Pancreas Transplant Allocation Policy on Pancreas Transplant Volume and Outcomes: A Single Center Study [abstract]. https://atcmeetingabstracts.com/abstract/impact-of-new-pancreas-transplant-allocation-policy-on-pancreas-transplant-volume-and-outcomes-a-single-center-study/. Accessed July 24, 2021.
« Back to 2018 American Transplant Congress